Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1996
03/27/1996EP0703295A1 Vaccine composition comprising recombinant BCG expressing gp 63 fusion protein
03/27/1996EP0703242A1 Human-origin tumor cell proliferation inhibiting factor
03/27/1996EP0702794A1 Method and analytical device for simultaneous immunoassay
03/27/1996EP0702730A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
03/27/1996EP0702725A1 Method for recombinant production of biologically active polypeptides
03/27/1996EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides
03/27/1996EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound
03/27/1996EP0702722A1 Plasmids suitable for gene therapy
03/27/1996EP0702721A1 Process for producing fusion proteins comprising scfv fragments by a transformed mould
03/27/1996EP0702720A1 Method for defined deletions of dna
03/27/1996EP0702717A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors
03/27/1996EP0702696A1 Trifunctional antithrombin and antiplatelet peptides
03/27/1996EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
03/27/1996EP0702694A1 $i(PSEUDOMONAS SYRINGAE) pv. $i(SYRINGAE hrpZ) GENE
03/27/1996EP0702693A1 Tandem synthetic hiv-1 peptides
03/27/1996EP0702692A1 Regulation of antigen presentation
03/27/1996EP0702689A1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids
03/27/1996EP0702570A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION
03/27/1996EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
03/27/1996EP0702564A1 Novel attenuated pseudomonas aeruginosa strains
03/27/1996EP0702558A1 Novel opioid peptide inhibitors
03/27/1996EP0607392A4 Plasma fraction purification.
03/27/1996EP0483224B1 Inducible expression vectors
03/27/1996CN1119459A Process for preparing cancer vaccines
03/27/1996CN1119458A Nucleic acid pharmaceuticals
03/27/1996CN1119457A Bone stimulating factor
03/27/1996CN1119442A Protein Rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
03/27/1996CN1119121A Crystalline interleukin-4
03/26/1996US5502176 Gene expression
03/26/1996US5502168 Polypeptides for malaria vaccines
03/26/1996US5502167 CDR grafted humanised chimeric T-cell antibodies
03/26/1996US5502166 Information transmission at a synapse, central nervous systems
03/26/1996US5502164 Peptide compounds having therapeutic activity
03/26/1996US5502163 By lactating cows
03/26/1996US5502061 Peptidyl substituted benzamides and naphthamies
03/26/1996US5502037 Antitumor agents for procytotoxic drugs
03/26/1996US5502034 Methods for producing thrombin
03/26/1996US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases
03/26/1996US5501987 Dual analyte immunoassay for methamphetamine and amphetamine
03/26/1996US5501976 Inhibit digestion and/or fertility
03/26/1996US5501975 Transformed host cell, dibasic processing endoprotease, improved yield of correctly folded proteins
03/26/1996US5501970 Nucleotide sequences coding for ribosome inactivating proteins
03/26/1996US5501969 Bone disorders, antitumor
03/26/1996US5501962 Culture of cells for polypeptides
03/26/1996US5501948 Coating onto a solid support having hepatitis antibodies, absence of denaturing environment
03/26/1996US5501853 Peptide plasminogen activators
03/26/1996CA1338183C Cyclic peptolides
03/21/1996WO1996008582A2 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
03/21/1996WO1996008573A1 Phytopathogenic dna virus resistant transgenic plants and seeds and methods for obtaining same
03/21/1996WO1996008572A1 Method for the production of recombinant proteins, plasmids and modified cells
03/21/1996WO1996008570A1 Expression and export technology of proteins as immunofusins
03/21/1996WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996WO1996008563A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
03/21/1996WO1996008562A1 Biologically active molecules derived from neurotrophins
03/21/1996WO1996008561A1 Method for detection of malfolded protein
03/21/1996WO1996008560A1 Transduction of genes into human hematopoietic stem cells using recombinant adeno-associated viral vectors
03/21/1996WO1996008514A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
03/21/1996WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
03/21/1996WO1996008512A1 POLYPEPTIDES WITH Fc BINDING ABILITY
03/21/1996WO1996008511A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN
03/21/1996WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
03/21/1996WO1996008509A1 Anti-fungal peptides
03/21/1996WO1996008508A1 A new human peptide antibiotic (fall-39) and its use
03/21/1996WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy
03/21/1996WO1996008275A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996WO1996008274A2 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents
03/21/1996WO1996008269A1 Inhibition of human rotavirus infection
03/21/1996WO1996008268A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996WO1996008265A1 Corticotropin release inhibiting factor and methods of using same
03/21/1996WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996WO1996008256A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
03/21/1996WO1996008231A1 Control of hair growth
03/21/1996WO1996008136A1 Pest trap plants and crop protection
03/21/1996WO1996006108A3 Cyclic cs-1 peptidomimetics, compositions and methods of using the same
03/21/1996WO1996005309A3 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/21/1996WO1996004382A3 Secreted viral proteins useful for vaccines and diagnostics
03/21/1996WO1996004373A3 Recombinant production of biologically active peptides and proteins
03/21/1996WO1995033819A3 Cdk4 (cyclin dependent kinase 4) binding proteins
03/21/1996WO1995032290A3 Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
03/21/1996WO1995020039A3 Customized proteases with altered transacylation activity
03/21/1996DE4435485C1 Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor Process for the recovery of high purity von Willebrand factor
03/21/1996DE4433479A1 Proteins isolated from Boophilus microplus
03/21/1996DE4433458A1 Proteins isolated from Desserobdella leeches
03/21/1996DE4432943A1 Selection of peptide(s) with high binding affinity for target protein
03/21/1996DE4432942A1 New synthetic inducible biological response amplifier
03/21/1996DE3249946C2 Target cell lysis factor prodn.
03/21/1996CA2219915A1 Pest trap plants and crop protection
03/21/1996CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy
03/21/1996CA2200087A1 Active induction or passive immunization of anti-gp48 antibodies and isolated gp48 protein
03/21/1996CA2200085A1 Control of hair growth
03/21/1996CA2199939A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996CA2199746A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996CA2199740A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
03/21/1996CA2199734A1 Corticotropin release inhibiting factor and methods of using same
03/21/1996CA2199719A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
03/21/1996CA2199707A1 Inhibition of human rotavirus infection
03/21/1996CA2198361A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996CA2198263A1 Method for detection of malfolded protein
03/21/1996CA2198248A1 Polypeptides with fc binding ability